No-Implant Interatrial Shunt for Heart Failure With Preserved Ejection Fraction: Six-Month Outcomes From Multi-center Pilot Feasibility Studies
We Recommend
Disclosures
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:
- Consultant Fee/Honoraria/Speaker's Bureau - Abbott; Boston Scientific Corporation; Medtronic; W.L. Gore & Associates; Philips; Alleviant Medical; Innovheart; ACIST
- Equity/Stock(s)/Options - Indian Wells; InterShunt